NCT04495868View on ClinicalTrials.gov

Bacteriostatic Normal Saline Versus Lidocaine for Intradermal Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

April 6, 2022

Study Completion Date

April 6, 2022

Conditions
Chronic Pain
Interventions
DRUG

Bacteriostatic Normal Saline

A skin wheal will be made with bacteriostatic normal saline (BNS). BNS contains 0.9% benzyl alcohol and benzyl alcohol is an opium alkaloid that is sometimes added to physiologic normal saline for its bacteriostatic properties. The skin wheal will be created by injecting the medication intra-dermally with a 26 gauge needle.

DRUG

1% Lidocaine

A skin wheal will be made with 1% lidocaine. The skin wheal will be created by injecting the medication intra-dermally with a 26 gauge needle.

Trial Locations (1)

30303

Grady Pain Clinic, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT04495868 - Bacteriostatic Normal Saline Versus Lidocaine for Intradermal Anesthesia | Biotech Hunter | Biotech Hunter